Our work

We are a Clinical Research Company which provides clinical; medical, regulatory services for the BioPharmaceutical Industry, unique in Argentina due to our exclusive specialization in executing Pharmacokinetic Studies, Phase I, Bioavailability and Bioequivalence.

Since 2003, with recognized credentials, our primary objective has been to provide the Local and International Industry with Clinical, Pharmacological, Regulatory, Bio Analytical and Statistical Services for the execution of Clinical Studies.

read more

Services

Services

We provide a broad range of services to support your drug development project from pre-registration to post-commercialization.

Research Units

Research Units

Inspected and Authorized by Argentina MoH (A.N.M.A.T.) and Chile MoH ( I.S.P.)

Our professionals

Our professionals

Our team of professionals is under continuous training program to guarantee the best quality performance.

News

We congratulate Laboratorio BETA for the declaration of #BIOEQUIVALENCE of the product DROPICINE®/RISPERIDONE, 1mg coated tablets.

By ANMAT regulation DI-2023-5343-APN-ANMAT#MS of July 18, 2023, the results of the Bioequivalence Study designed, carried out and analyzed by FP CLINICAL PHARMA were accepted. This allowed us to decl

Read more

We are pleased to inform you that by Provision DI-2023-6029-APN-ANMAT#MS of August 7, 2023

The National Administration of Drugs, Food and Medical Technology has renewed the Authorization of FP Clinical Pharma S.R.L. to carry out PHASE IV CLINICAL PHARMACOLOGY STUDIES OF BIOEQUIVALENCE IN AD

Read more

0

Years of experience

0

Research projects

0

Clients

0

Molecules

0

Patients / Volunteers

Certifications